Best VCs for Medical Technology

37 venture capitalists actively investing in Medical Technology.

37
Active VCs
0
Funds
0
Deals
#1Alan Abbott

SLP & Venture Partner

Cottonwood Technology Fund

Alan Abbott contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#2Ytsen van der Meer

Principal

Cottonwood Technology Fund

Ytsen van der Meer contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europ

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#3Sabine Jansen

Corporate & Investor Relations

Cottonwood Technology Fund

Sabine Jansen contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#4Shinjan Dasgupta

Technology Analyst

Cottonwood Technology Fund

Shinjan Dasgupta contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#5Daan Boekhoudt

Investment Analyst

Cottonwood Technology Fund

Daan Boekhoudt contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#6Charles Call

SLP & Venture Partner

Cottonwood Technology Fund

Charles Call contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#7Bill Baumel

Managing Director

Ohio Innovation Fund

Bill Baumel invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS and

$500K-$4M, as published by Ohio Innovation Fund.
Early Stage
#8Michael Hughes

Venture Partner

Ohio Innovation Fund

Michael Hughes invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS a

$500K-$4M, as published by Ohio Innovation Fund.
Early Stage
#9Mike Triplett

Venture Partner

Ohio Innovation Fund

Mike Triplett invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS an

$500K-$4M, as published by Ohio Innovation Fund.
Early Stage
#10Jeff Schumann

Venture Advisor

Ohio Innovation Fund

Jeff Schumann is listed in a Venture Advisor capacity at Ohio Innovation Fund. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction

$500K-$4M, as published by Ohio Innovation Fund.
Early Stage
#11Faith Voinovich

Principal

Ohio Innovation Fund

Faith Voinovich invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS

$500K-$4M, as published by Ohio Innovation Fund.
Early Stage
#12Christy Shaffer

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#13Douglas Reed

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#14Kim Hodges

Chief Financial Officer

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#15Fred Goldwater

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#16Holden Thorp

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#17Ben Scruggs

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#18Kseniya Simpson

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#19Alston Gardner

Special Advisor

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#20Parker Johnson

Head of Investor Relations

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#21Graham Smith

Associate

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#22Declan Devens

Operations Analyst

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#23Lauren P Flickinger

Partner and Fund Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#24Myla Lai-Goldman

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#25Kirkland Hendrickson

Program Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#26Heather Madsen

Operating Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#27John Crumpler

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#28Clay B. Thorp

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#29Kenneth B. Lee, Jr.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#30Dave Blivin

Managing Partner

Cottonwood Technology Fund

Dave Blivin contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#31Alain le Loux

General Partner

Cottonwood Technology Fund

Alain le Loux contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#32Lee Rand

Partner

Cottonwood Technology Fund

Lee Rand contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Pre-SeedSeedEarly Stage
#33Hylton Kalvaria

Advisor

Rock Health Capital

Hylton Kalvaria is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and use

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#34Keith W. Anderson

Advisor

Rock Health Capital

Keith W. Anderson is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and u

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#35Monique Smith

Advisor

Rock Health Capital

Monique Smith is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#36Bill Evans

Founder and General Partner

Rock Health Capital

Bill Evans invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthc

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage
#37Sean Day

Principal

Rock Health Capital

Sean Day invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcar

Rock Health Capital does not publish a standard current check-size range on its official site.
SeedEarly Stage